New research suggests that patients who discontinue blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who halt traditional lifestyle regimens.
Research printed in a prominent health publication shows that while overweight people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using these treatments need to be aware of the danger of rapid rebound weight gain when the therapy is stopped," stated expert Dr. Susan Jebb.
This pace of recovery suggests a return to original weight in about a year and a half.
Comparing Treatments
The study, which looked at dozens of studies involving over 9,000 of participants, compared the outcomes of the injectable medications with conventional dieting.
Researchers emphasize that individuals who lose weight through dieting generally have a more gradual weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Fast Regain
Experts suggest the way of the injections explains the accelerated regain.
The injections copy a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' results in hunger is uncontrolled, making excessive eating a significant risk."
An Ongoing Disease?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
A number of clinicians say that, given the likelihood of weight regain, the therapy is often life-long.
This opinion is supported by pharmaceutical companies, who state that the results "highlight the long-term nature of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have discontinued the jabs explain a sudden resurgence of appetite.
"It was like a trigger flipping and you're instantly starving," said a patient.
This challenge is exacerbated if patients have not developed permanent lifestyle or habit changes during treatment.
Significant Interest
Survey data show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is more common among females than males.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while these medications are powerful tools for weight loss, they are not a permanent fix and maintained weight loss likely depends on integrated behavioural management.
